These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16859169

  • 1. [Substance properties of zoledronate make it possible: bisphosphonate therapy only once yearly].
    MMW Fortschr Med; 2006 Jun 22; 148(25):60-1. PubMed ID: 16859169
    [No Abstract] [Full Text] [Related]

  • 2. [Postmenopausal osteoporosis. Bisphosphonates are not all equal].
    MMW Fortschr Med; 2009 Mar 12; 151(11):46-7. PubMed ID: 19469206
    [No Abstract] [Full Text] [Related]

  • 3. [Osteoporosis therapy. Bisphosphonates compared].
    MMW Fortschr Med; 2003 Mar 27; 145(13):60. PubMed ID: 15101545
    [No Abstract] [Full Text] [Related]

  • 4. [FACT study: benefits of alendronate].
    MMW Fortschr Med; 2005 Jan 13; 147(1-2):52-3. PubMed ID: 15704574
    [No Abstract] [Full Text] [Related]

  • 5. Going on a drug holiday?
    Bonnick SL.
    J Clin Densitom; 2011 Jan 13; 14(4):377-83. PubMed ID: 22051091
    [No Abstract] [Full Text] [Related]

  • 6. [To increase bone density faster and stronger].
    MMW Fortschr Med; 2005 May 05; 147(18):44-5. PubMed ID: 15934589
    [No Abstract] [Full Text] [Related]

  • 7. [Patient compliance program aids therapy success].
    MMW Fortschr Med; 2009 Mar 12; 151(11):47. PubMed ID: 19469207
    [No Abstract] [Full Text] [Related]

  • 8. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov 05; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
    McClung M, Recker R, Miller P, Fiske D, Minkoff J, Kriegman A, Zhou W, Adera M, Davis J.
    Bone; 2007 Jul 05; 41(1):122-8. PubMed ID: 17468062
    [Abstract] [Full Text] [Related]

  • 10. [FACT study].
    Tanaka I, Oshima H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():280-5. PubMed ID: 18161120
    [No Abstract] [Full Text] [Related]

  • 11. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB.
    Ann Pharmacother; 2008 Jul 28; 42(7):1085-9. PubMed ID: 18505912
    [Abstract] [Full Text] [Related]

  • 12. Is a single infusion of zoledronic acid more effective than oral risedronate for the treatment of patients with Paget's disease?
    Krane SM.
    Nat Clin Pract Rheumatol; 2006 Apr 28; 2(4):186-7. PubMed ID: 16932682
    [No Abstract] [Full Text] [Related]

  • 13. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis.
    Cramer JA, Amonkar MM, Hebborn A, Altman R.
    Curr Med Res Opin; 2005 Sep 28; 21(9):1453-60. PubMed ID: 16197664
    [Abstract] [Full Text] [Related]

  • 14. Annual zoledronic acid for osteoporosis.
    BMJ Group.
    Drug Ther Bull; 2008 Dec 28; 46(12):93-6. PubMed ID: 19056701
    [Abstract] [Full Text] [Related]

  • 15. [Osteoporosis and bisphosphonates].
    Zuber MA.
    Z Rheumatol; 2007 Dec 28; 66(8):713-5. PubMed ID: 17955251
    [No Abstract] [Full Text] [Related]

  • 16. [Men also need bone protection].
    MMW Fortschr Med; 2006 Nov 16; 148(46):48-9. PubMed ID: 17615790
    [No Abstract] [Full Text] [Related]

  • 17. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug 16; 18(102):175. PubMed ID: 19746563
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
    Fitzpatrick SG, Stavropoulos MF, Bowers LM, Neuman AN, Hinkson DW, Green JG, Bhattacharyya I, Cohen DM.
    J Oral Maxillofac Surg; 2012 Feb 16; 70(2):325-30. PubMed ID: 21723015
    [No Abstract] [Full Text] [Related]

  • 19. [Correlation between studies and general practice].
    MMW Fortschr Med; 2006 Nov 16; 148(46):49. PubMed ID: 17615791
    [No Abstract] [Full Text] [Related]

  • 20. A double-blinded head-to-head trial of minodronate and alendronate in women with postmenopausal osteoporosis.
    Hagino H, Nishizawa Y, Sone T, Morii H, Taketani Y, Nakamura T, Itabashi A, Mizunuma H, Ohashi Y, Shiraki M, Minamide T, Matsumoto T.
    Bone; 2009 Jun 16; 44(6):1078-84. PubMed ID: 19264155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.